Walled-off necrosis (WON) is a pancreatic fluid collection, which contains necrotic tissue after four weeks of the onset of acute pancreatitis. Interventions are required to manage patients with infected WON, for which endoscopic ultrasonography (EUS)-guided drainage has become a first-line treatment modality. For patients who are refractory to EUS-guided drainage, the step-up treatment including endoscopic necrosectomy (EN) and/or additional drainage is considered to subside the infection. Recent evidence suggests that EN immediately after EUS-guided drainage may shorten treatment duration without increasing adverse events. In this randomized trial, the investigators will compare treatment duration between EN immediately after EUS-guided drainage versus the step-up approach in patients with symptomatic WON.
Pancreatic fluid collection is a late complication of severe acute pancreatitis. According to the revised Atlanta classification, walled-off necrosis (WON) is defined as an encapsulated collection of necrotic tissue that is observed after four weeks of the onset of acute pancreatitis. Infected WON is associated with high morbidity and mortality; therefore, an appropriate treatment, including antibiotics and drainage, is mandatory. With the development of endoscopic equipment, endoscopic ultrasonography (EUS)-guided drainage has become a first-line treatment modality for infected WON. For patients who are refractory to EUS-guided drainage, endoscopic necrosectomy (EN) is a treatment option to facilitate direct removal of infected necrotic tissue within the WON. However, due to potentially lethal adverse events of EN, such as bleeding, perforation, and peritonitis, EN is usually withheld for several days after EUS-guided drainage. This strategy is known as "the step-up approach." Recently, with the accumulated evidence supporting the safety of EN, especially with the use of a dedicated lumen-apposing metal stent, it has been reported that EN immediately after EUS-guided drainage can shorten the treatment duration without increasing adverse events. Given these lines of evidence, the investigators hypothesized that immediate EN following EUS-guided drainage of WON might shorten time to clinical success compared to the step-up approach. To examine this hypothesis, the investigators planned to conduct a multicenter randomized controlled trial comparing treatment duration between EN immediately after EUS-guided drainage versus the step-up approach in patients with symptomatic WON.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
70
Endoscopic ultrasonography (EUS)-guided drainage will be conducted within 72 hours from randomization. A convex-type echoendoscope is advanced to the stomach or duodenum, and the walled-off necrosis (WON) is visualized and punctured under EUS guidance. A lumen-apposing metal stent (LAMS), such as Hot AXIOS system (Boston Scientific Japan, Tokyo, Japan), is recommended for the initial EUS-guided drainage. For the immediate necrosectomy group, endoscopic necrosectomy (EN) will be performed in the same session of EUS-guided drainage using a gastroscope. The endoscope is inserted into the WON cavity through the LAMS, and necrotic tissue is removed using biopsy forceps, snare, or basket catheter. The EN procedures will be repeated until clinical improvement.
Endoscopic ultrasonography (EUS)-guided drainage will be conducted within 72 hours from randomization. A convex-type echoendoscope is advanced to the stomach or duodenum, and the walled-off necrosis (WON) is visualized and punctured under EUS guidance. A lumen-apposing metal stent (LAMS), such as Hot AXIOS system (Boston Scientific Japan, Tokyo, Japan), is recommended for the initial EUS-guided drainage. For the step-up approach group, an additional interventional procedure will be withheld for 72-96 hours after initial EUS-guided drainage. In cases without clinical improvement after 72-96 hours, additional drainage will be permitted, which includes increasing the number of stents, additional EUS-guided drainage, and performing percutaneous drainage (step-up treatment). Insufficient improvement even after two times of step-up treatment allows subsequent endoscopic necrosectomy (EN).
Department of Gastroenterology, The University of Tokyo Hospital
Bunkyō-Ku, Tokyo, Japan
NOT_YET_RECRUITINGDepartment of Gastroenterology, Graduate School of Medicine, Juntendo University
Bunkyō-Ku, Tokyo, Japan
RECRUITINGDepartment of Gastroenterology, Aichi Medical University
Aichi, Japan
RECRUITINGDepartment of Gastroenterology, Graduate School of Medicine, Chiba University
Chiba, Japan
Time to clinical success from randomization
Clinical success is defined as 1) a decrease in the WON size to 3 cm or less and 2) an improvement of more than two out of the three following inflammatory markers; body temperature, white blood cell count, and C-reactive protein.
Time frame: Six months
Adverse events
All procedure-related adverse events including bleeding, perforation, peritonitis, etc.
Time frame: Five years
Mortality
Mortality from any cause
Time frame: Five years
Technical success rate of initial EUS-PCD (Endoscopic ultrasonography-guided pseudocyst drainage)
Successful placement of EUS-guided drainage including a lumen-apposing metal stent and plastic stents
Time frame: One day
Incidence of biliary and gastrointestinal stricture
Inflammatory-induced obstruction of bile duct and gastrointestinal tract
Time frame: Five years
Number and time of interventions
Total number of interventions and total procedure time
Time frame: Six months
Indwelling time of endoscopic and percutaneous drainage
Indwelling period of stents and drainage tube
Time frame: Six months
Success rate and operation time of surgical procedures
Success rate of surgeries associated with WON and total operation time
Time frame: Six months
Hospital stay and ICU stay
Total hospitalization days and total ICU stay
Time frame: Six months
Duration of antibiotics administration
Total administration days of antibiotics
Time frame: Six months
Cost of interventions and hospital stay
Total cost of interventions and total cost of hospitalization
Time frame: Six months
Recurrence of WON
Incidence of recurrence of WON
Time frame: Five years
Time to recurrence of WON
Time from clinical success to recurrence of WON
Time frame: Five years
Treatment duration of recurrent WON
Total treatment period for recurrent WON
Time frame: Five years
New onset of pseudocyst
Incidence of new-onset pancreatic pseudocyst
Time frame: Five years
Treatment duration of new onset pseudocyst
Total treatment period for new-onset pancreatic pseudocyst
Time frame: Five years
Incidence of new onset diabetes, clinical symptoms of pancreatic exocrine insufficiency, and pancreatic cancer
New-onset diabetes mellitus, pancreatic cancer, and clinical symptoms associated with pancreatic exocrine insufficiency, such as steatorrhea , constipation, diarrhea, maldigestion, flatulence, and tenesmus
Time frame: Five years
The presence and timing of medications for pancreatic exocrine insufficiency
The start of medications for pancreatic exocrine insufficiency and the date
Time frame: Five years
The presence and timing of sarcopenia
The presence of sarcopenia and the date of diagnosis
Time frame: Five years
Morphological change of pancreas
Change in the morphology and the volume of pancreas
Time frame: Five years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Department of Gastroenterology, Gifu Municipal Hospital
Gifu, Japan
RECRUITINGDepartment of Gastroenterology, Gifu Prefectural General Medical Center
Gifu, Japan
RECRUITINGFirst Department of Internal Medicine, Gifu University Hospital
Gifu, Japan
NOT_YET_RECRUITINGDivision of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University
Hyōgo, Japan
RECRUITINGDepartment of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University
Kagawa, Japan
RECRUITINGDigestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences
Kagoshima, Japan
RECRUITING...and 11 more locations